Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEET

v3.22.2.2
CONDENSED CONSOLIDATED BALANCE SHEET - USD ($)
Sep. 30, 2022
Dec. 31, 2021
CURRENT ASSETS:    
Cash $ 3,385,974 $ 8,901,875
Prepaid expenses 342,565 58,078
Total current assets 3,728,539 8,959,953
PROPERTY AND EQUIPMENT, NET 0 0
OTHER ASSETS    
Operating lease - right of use asset 210,759 27,225
Security deposit 32,058 3,000
Total other assets 242,817 30,225
TOTAL ASSETS 3,971,356 8,990,178
CURRENT LIABILITIES:    
Accounts payable 606,981 654,333
Current portion of long-term operating lease 92,723 15,178
Convertible debentures payable 240,000 240,000
Deferred R&D obligations - participation agreements 579,880 1,106,320
Deferred R&D obligations - participation agreements related parties 193,432 369,037
Accrued interest 97,681 95,886
Accrued liabilities - payroll and directors fees 364,815 467,215
Note payable 139,689 0
Total Current Liabilities 2,315,201 2,947,969
LONG-TERM LIABILITIES:    
Long-term operating lease, net of current portion 131,910 0
Total long-term liabilities 131,910 0
TOTAL LIABILITIES 2,447,111 2,947,969
STOCKHOLDERS' EQUITY:    
Common stock, $0.001 par value, 150,000,000 shares authorized; 9,419,660 and 9,419,660 issued and outstanding at September 30, 2022 and December 31, 2021 9,420 9,420
Additional paid-in capital 114,678,559 113,092,025
Accumulated deficit (113,163,734) (107,059,236)
Total stockholders' equity 1,524,245 6,042,209
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 3,971,356 $ 8,990,178